Summary

The global Omega-3 Supplements for Pet market is projected to grow from US$ 382 million in 2025 to US$ 559 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Omega-3 Supplements for Pet refers to finished nutritional supplement products formulated for dogs, cats and other companion animals, in which omega-3 polyunsaturated fatty acids are the principal functional nutrients. The market primarily covers standalone liquid oils, softgels/capsules, soft chews, powders, emulsions and related supplemental formats administered in addition to the animal’s regular diet. Core active fatty acids include eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and, in selected plant-derived products, alpha-linolenic acid (ALA). Major ingredient sources include marine fish oil, krill oil, microalgal oil and plant oils, while commercially differentiated products may also incorporate antioxidants, flavoring or palatability systems and complementary nutritional ingredients. Product quality is evaluated through EPA and DHA content per serving, total omega-3 concentration, source and traceability, oxidation stability, contaminant control, dosage accuracy, palatability and shelf stability. The research scope focuses on independently marketed Omega-3 Supplements for Pet used primarily for skin and coat, joint and mobility, cardiovascular, cognitive, visual and general nutritional support. In the U.S. regulatory framework, fatty-acid nutritional supplements for pets are treated within the animal-feed/pet-food framework, while European nutritional guidance similarly recognizes omega-3 fatty acids as relevant components of canine and feline nutrition.
Key Findings
Fish oil remains the mainstream commercial source, with EPA and DHA serving as the principal value-defining active ingredients
Liquid oils, softgels and soft chews form the core commercial dosage formats
Dogs represent the broadest application base, while cat-specific products emphasize dosage control and palatability
Quality differentiation increasingly centers on EPA+DHA concentration, oxidation control, traceability and formulation convenience
In 2025, global omega-3 supplements for pet production reached approximately 1091.6 k units, the average price is 35 usd/unit
Market Trends
Omega-3 Supplements for Pet is moving from basic fish-oil supplementation toward a more segmented functional-nutrition market. Conventional liquid marine oils remain important because they provide relatively high EPA and DHA content at competitive cost, but softgels and soft chews are gaining strategic relevance where convenience, dosing accuracy and palatability influence repeat purchase. Established brands increasingly differentiate products by actual EPA+DHA delivered per serving rather than total fish-oil quantity, while triglyceride and re-esterified triglyceride oils, sustainably sourced marine ingredients and specialized formulations are used to support premium positioning. The ingredient base is also diversifying. Fish oil remains the mainstream platform, but krill and microalgal oils provide alternative sourcing routes, particularly for premium, sustainability-oriented and non-fish positioning. FDA-reviewed information confirms that Schizochytrium-derived algal oil containing EPA and DHA can serve as a nutritive ingredient for dogs. At the finished-product level, leading product portfolios already span liquids, softgels and soft chews, indicating that formulation convenience is becoming almost as important as the underlying lipid source.
Market Dynamics
Drivers
The principal driver is the continuing shift in pet ownership toward proactive nutritional management and more specialized companion-animal wellness products. Omega-3 fatty acids are particularly well suited to this trend because EPA and DHA can be incorporated into products addressing multiple recurring nutritional-support needs, including skin and coat condition, joint mobility, cardiovascular health, brain and visual function and overall wellness. The category also benefits from a replenishment-based purchase model: liquid oils, capsules and chews are consumed continuously rather than purchased as durable products. Veterinary recommendation provides an additional demand pathway, especially for products with clearly declared EPA/DHA dosage and quality controls. Current commercial portfolios demonstrate that the same active ingredient platform can be segmented by species, body weight, life stage, delivery format and functional claim. Nutramax’s Welactin, for example, currently offers liquid, softgel and soft-chew formats for dogs and cats, while Nordic Naturals provides differentiated pet products and weight-based feeding recommendations.
Restraints
Market expansion is constrained by raw-material quality variability, oxidation sensitivity, product-price dispersion and regulatory limitations on claims. Omega-3 oils are susceptible to oxidative deterioration during processing, storage and consumer use; poor control can affect odor, palatability, shelf life and perceived product quality. The broader omega-3 industry therefore uses peroxide value, p-anisidine value and TOTOX as important oxidation indicators, alongside contaminant and heavy-metal control. Another constraint is that consumers can find omega-3 fatty acids in complete pet food, functional treats and standalone supplements, which increases substitution between product formats and complicates communication of incremental nutritional value. Regulatory positioning also requires careful management. AAFCO states that nutrient supplements such as fatty acids are treated as pet food under U.S. animal-feed regulations, while disease-treatment or prevention claims can move products toward drug regulation. This limits the extent to which brands can use therapeutic language even when products are marketed through veterinary-oriented channels.
Opportunities
The strongest opportunities lie in premiumization, alternative omega-3 sources and more precise dose delivery. Products with higher EPA+DHA concentration can provide the required amount in smaller serving volumes, supporting premium positioning and improving convenience for smaller dogs and cats. Krill and microalgal oils create additional differentiation through alternative lipid composition, sustainability narratives and reduced reliance on conventional marine fish supply chains. Soft-chew formats offer another avenue for value creation because they combine supplementation with treat-like administration and can incorporate complementary ingredients targeted at skin, joint, immune or digestive support. There is also room for greater species and life-stage segmentation, particularly cat-specific products, where small serving size and palatability are more demanding. Quality certification and traceability represent an additional commercial opportunity: NASC’s industry framework emphasizes audited quality systems, production controls, adverse-event systems, label compliance and independent product testing, increasing the value of transparent manufacturing and verified label claims.
Challenges
The major challenge is converting a chemically familiar ingredient into a defensible branded product in a crowded pet-supplement environment. Two products can both be marketed as fish oil while differing materially in EPA+DHA concentration, serving size, oxidation status, source traceability and stability after opening. Brands therefore need to communicate effective dosage rather than relying only on gross oil content. Palatability is particularly important because oxidation or strong marine odor can reduce compliance in daily feeding, undermining repeat purchase. Supply-chain quality also requires ongoing control of contaminants, oxidation and batch variability. At the regulatory level, the absence of a human-style dietary-supplement category for animals in the U.S. makes ingredient acceptability, labeling and claims management an important operating capability. AAFCO specifically notes that animal products are regulated as food/feed or drugs rather than under the human dietary-supplement framework. At the same time, growing reliance on contract manufacturing creates an additional challenge for brands: product consistency, traceability and quality responsibility must be maintained even when formulation, encapsulation or packaging is outsourced.
Industry Chain Analysis
The upstream industry chain begins with marine fisheries, fish-processing by-products, krill harvesting, microalgae fermentation and oilseed agriculture. These feedstocks are converted into crude fish, krill, algal or plant oils before undergoing refining, deodorization, contaminant removal, concentration and stabilization. Higher-value marine omega-3 ingredients may be standardized to specific EPA and DHA levels and supplied in triglyceride, re-esterified triglyceride or other commercially relevant lipid forms. Microalgal routes use controlled fermentation and downstream separation to produce EPA/DHA-rich oils; FDA-reviewed material for Schizochytrium-derived oil describes fermentation, enzymatic treatment, centrifugation and controlled drying as part of the production process. Quality and cost at this stage are influenced by EPA/DHA concentration, raw-material origin, purification intensity, sustainability certification, oxidation stability and contaminant specifications. NASC’s supplier framework also demonstrates the presence of dedicated omega-3 ingredient suppliers serving pet-health formulations.
Midstream manufacturers formulate and convert these oils into finished Omega-3 Supplements for Pet through blending, antioxidant stabilization, flavor and palatability adjustment, encapsulation, soft-chew manufacturing, filling and packaging. The industry combines vertically integrated brands, specialist pet-supplement manufacturers and contract manufacturing/OEM models. Downstream distribution spans veterinary clinics, pet-specialty stores, mass retail, e-commerce and brand-direct channels. Value creation therefore extends beyond the raw oil itself: formulation accuracy, EPA/DHA dosing, oxidation management, dosage convenience, packaging protection, quality testing, brand credibility and channel access all contribute to finished-product pricing. NASC confirms that audited pet supplements are sold across veterinary, specialty pet, supermarket, big-box and online channels, illustrating the category’s multi-channel structure.
Segment Insights
By ingredient source, fish-oil-based products remain the central commercial segment because they provide established access to long-chain EPA and DHA and can be offered across both mass-market and premium price tiers. Within this segment, differentiation is increasingly driven by species of origin, concentration, purification, triglyceride form, sustainable sourcing and freshness rather than by the generic “fish oil” label. Krill-based products occupy a more premium niche, while algal oil has strategic potential as a scalable alternative source of long-chain omega-3 fatty acids. Plant-based products primarily supply ALA and therefore occupy a different nutritional position from direct EPA/DHA supplements. This distinction is important for market segmentation because products with similar “Omega-3” labels can deliver materially different active-fatty-acid profiles.
By dosage form, liquid oils provide efficient delivery of relatively large EPA+DHA doses and remain well suited to daily food-topper use. Softgels provide measured dosing and better protection of the oil from repeated bottle opening, while soft chews offer higher convenience and palatability and can support greater formulation value through additional functional ingredients. Current leading portfolios already use all three formats: Welactin markets liquid, softgel and soft-chew products, while Nordic Naturals offers liquid and softgel Omega-3 Pet products alongside functional pet soft chews. This indicates a market moving toward dosage-form segmentation rather than a single dominant physical format.
Downstream Market Opportunities
Dogs form the broadest downstream opportunity because products can be differentiated across a wide body-weight range and numerous functional-support needs, allowing manufacturers to offer multiple serving strengths and package sizes. Cats represent a smaller but strategically attractive segment in which concentrated oils, small-dose liquid formats and palatability become particularly important. Skin and coat support remains one of the most established consumer-facing applications, while joint and mobility, cardiovascular, cognitive, brain and vision support expand the functional positioning of EPA/DHA products. Veterinary-oriented channels create opportunities for higher-concentration and more precisely dosed formulations, whereas e-commerce and pet-specialty retail favor easy-to-understand formats such as pumps, soft chews and daily softgels. The downstream opportunity therefore lies not only in increasing pet supplement penetration, but also in matching dose, formulation and delivery format more precisely to species, body weight and owner administration preferences. Current commercial products already demonstrate weight-based dosing and species-specific formulations for both dogs and cats.
Regional Insights
North America is a key mature market for Omega-3 Supplements for Pet, supported by a dense specialist-brand base, established veterinary and pet-specialty channels and an institutionalized animal-supplement quality ecosystem. The confirmed supplier database includes numerous U.S.-based brands spanning veterinary products, premium fish oils, soft chews and direct-to-consumer offerings. NASC’s member and quality-audit framework further illustrates the depth of the U.S. animal-supplement ecosystem and the importance placed on production controls, labeling and independent verification. Europe has a strong animal-health and veterinary-nutrition position, supported by established manufacturers and FEDIAF’s nutritional framework for complete and complementary foods for dogs and cats.
Asia represents a growing manufacturing and brand-development base. China has developed an increasingly broad domestic pet-nutrition supply chain covering branded finished supplements, softgel and liquid-oil manufacturing and OEM/ODM production, with confirmed companies in the current study. Regional competition is therefore becoming more differentiated: mature Western markets emphasize formulation credibility, veterinary positioning and premium quality, while China combines expanding domestic pet-health consumption with increasingly capable local manufacturing and contract-production infrastructure.
Competitive Landscape Analysis
The Omega-3 Supplements for Pet market is fragmented across specialist omega-3 brands, veterinary-health companies, diversified pet-supplement groups and vertically integrated Chinese pet-nutrition manufacturers. Nordic Naturals competes through specialist omega-3 expertise, differentiated fish-oil formats and strong quality positioning; Nutramax Laboratories uses the Welactin platform to address veterinary-oriented dog and cat applications across liquid, softgel and soft-chew formats; Vetoquinol, Dechra Pharmaceuticals and Virbac participate through broader companion-animal health portfolios. FoodScience, H&H Group, Grizzly Pet Products, Standard Process, Rx Vitamins, Wholistic Pet Organics, Native Pet and other confirmed brands create additional competition across veterinary, specialty retail and online channels. Competitive advantage increasingly depends on verifiable EPA+DHA delivery, oxidation and contaminant control, ingredient traceability, palatability, formulation differentiation, manufacturing quality and access to trusted retail or veterinary channels. Contract manufacturing is common, so brand-level sales and OEM manufacturing revenue must be separated when assessing company market shares to avoid double counting.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Omega-3 Supplements for Pet market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Source and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Barlean’s
Compana Pet Brands
H&H Group
FoodScience
PawMedica
Vital Pet Life
StrellaLab LLC
Waggedy
Nordic Naturals
Vetoquinol
Nutramax Laboratories, Inc.
Dechra Pharmaceuticals
Virbac
Grizzly Pet Products
Standard Process
Swedencare
Veterinarian Recommended Solutions
Wholistic Pet Organics
Native Pet
AdvaCare Pharma
Four Leaf Rover
Shenzhen RedDog Biotechnology Co., Ltd.
Shanghai Chongxing Pet Products Co., Ltd.
Nanjing Xintengrui Biotechnology Co., Ltd.
Gambol Pet Group Co., Ltd.
Huasheng Weike Bioengineering (Luohe) Co., Ltd.
Segment by Source
Fish Oil-based Omega-3 Supplements
Krill Oil-based Omega-3 Supplements
Algal Oil-based Omega-3 Supplements
Plant-based Omega-3 Supplements
Segment by Shape
Liquid Oil
Softgel/Capsule
Soft Chew
Powder
Emulsion
Segment by Materials
EPA and DHA-based Omega-3 Supplements
ALA-based Omega-3 Supplements
Mixed Omega-3 Supplements
Segment by Application
Cat
Dog
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Omega-3 Supplements for Pet study scope, segments the market by Source and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Omega-3 Supplements for Pet: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Source
1.2.1 Global Omega-3 Supplements for Pet Market Size by Source, 2021 vs 2025 vs 2032
1.2.2 Fish Oil-based Omega-3 Supplements
1.2.3 Krill Oil-based Omega-3 Supplements
1.2.4 Algal Oil-based Omega-3 Supplements
1.2.5 Plant-based Omega-3 Supplements
1.3 Market Segmentation by Shape
1.3.1 Global Omega-3 Supplements for Pet Market Size by Shape, 2021 vs 2025 vs 2032
1.3.2 Liquid Oil
1.3.3 Softgel/Capsule
1.3.4 Soft Chew
1.3.5 Powder
1.3.6 Emulsion
1.4 Market Segmentation by Materials
1.4.1 Global Omega-3 Supplements for Pet Market Size by Materials, 2021 vs 2025 vs 2032
1.4.2 EPA and DHA-based Omega-3 Supplements
1.4.3 ALA-based Omega-3 Supplements
1.4.4 Mixed Omega-3 Supplements
1.5 Market Segmentation by Application
1.5.1 Global Omega-3 Supplements for Pet Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Cat
1.5.3 Dog
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Omega-3 Supplements for Pet Revenue Estimates and Forecasts (2021-2032)
2.2 Global Omega-3 Supplements for Pet Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Omega-3 Supplements for Pet Sales Estimates and Forecasts (2021-2032)
2.4 Global Omega-3 Supplements for Pet Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Omega-3 Supplements for Pet Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Omega-3 Supplements for Pet Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Fish Oil-based Omega-3 Supplements: Market Share by Key Manufacturers
3.5.2 Krill Oil-based Omega-3 Supplements: Market Share by Key Manufacturers
3.5.3 Algal Oil-based Omega-3 Supplements: Market Share by Key Manufacturers
3.5.4 Plant-based Omega-3 Supplements: Market Share by Key Manufacturers
3.6 Global Omega-3 Supplements for Pet Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Omega-3 Supplements for Pet Sales Performance by Source
4.1.1 Global Omega-3 Supplements for Pet Sales Volume by Source (2021-2032)
4.1.2 Global Omega-3 Supplements for Pet Revenue by Source (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Source (2021-2032)
4.2 Global Omega-3 Supplements for Pet Sales Performance by Shape
4.2.1 Global Omega-3 Supplements for Pet Sales Volume by Shape (2021-2032)
4.2.2 Global Omega-3 Supplements for Pet Revenue by Shape (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Shape (2021-2032)
4.3 Global Omega-3 Supplements for Pet Sales Performance by Materials
4.3.1 Global Omega-3 Supplements for Pet Sales Volume by Materials (2021-2032)
4.3.2 Global Omega-3 Supplements for Pet Revenue by Materials (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Materials (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Omega-3 Supplements for Pet Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Omega-3 Supplements for Pet Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Omega-3 Supplements for Pet Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Omega-3 Supplements for Pet Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Omega-3 Supplements for Pet Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Omega-3 Supplements for Pet Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Omega-3 Supplements for Pet Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Omega-3 Supplements for Pet Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Omega-3 Supplements for Pet Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Omega-3 Supplements for Pet Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Omega-3 Supplements for Pet Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Omega-3 Supplements for Pet Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Barlean’s
11.1.1 Barlean’s Corporation Information
11.1.2 Barlean’s Business Overview
11.1.3 Barlean’s Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.1.4 Barlean’s Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Barlean’s Omega-3 Supplements for Pet Sales by Product in 2025
11.1.6 Barlean’s Omega-3 Supplements for Pet Sales by Application in 2025
11.1.7 Barlean’s Omega-3 Supplements for Pet Sales by Geographic Area in 2025
11.1.8 Barlean’s Omega-3 Supplements for Pet SWOT Analysis
11.1.9 Barlean’s Recent Developments
11.2 Compana Pet Brands
11.2.1 Compana Pet Brands Corporation Information
11.2.2 Compana Pet Brands Business Overview
11.2.3 Compana Pet Brands Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.2.4 Compana Pet Brands Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Compana Pet Brands Omega-3 Supplements for Pet Sales by Product in 2025
11.2.6 Compana Pet Brands Omega-3 Supplements for Pet Sales by Application in 2025
11.2.7 Compana Pet Brands Omega-3 Supplements for Pet Sales by Geographic Area in 2025
11.2.8 Compana Pet Brands Omega-3 Supplements for Pet SWOT Analysis
11.2.9 Compana Pet Brands Recent Developments
11.3 H&H Group
11.3.1 H&H Group Corporation Information
11.3.2 H&H Group Business Overview
11.3.3 H&H Group Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.3.4 H&H Group Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 H&H Group Omega-3 Supplements for Pet Sales by Product in 2025
11.3.6 H&H Group Omega-3 Supplements for Pet Sales by Application in 2025
11.3.7 H&H Group Omega-3 Supplements for Pet Sales by Geographic Area in 2025
11.3.8 H&H Group Omega-3 Supplements for Pet SWOT Analysis
11.3.9 H&H Group Recent Developments
11.4 FoodScience
11.4.1 FoodScience Corporation Information
11.4.2 FoodScience Business Overview
11.4.3 FoodScience Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.4.4 FoodScience Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 FoodScience Omega-3 Supplements for Pet Sales by Product in 2025
11.4.6 FoodScience Omega-3 Supplements for Pet Sales by Application in 2025
11.4.7 FoodScience Omega-3 Supplements for Pet Sales by Geographic Area in 2025
11.4.8 FoodScience Omega-3 Supplements for Pet SWOT Analysis
11.4.9 FoodScience Recent Developments
11.5 PawMedica
11.5.1 PawMedica Corporation Information
11.5.2 PawMedica Business Overview
11.5.3 PawMedica Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.5.4 PawMedica Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 PawMedica Omega-3 Supplements for Pet Sales by Product in 2025
11.5.6 PawMedica Omega-3 Supplements for Pet Sales by Application in 2025
11.5.7 PawMedica Omega-3 Supplements for Pet Sales by Geographic Area in 2025
11.5.8 PawMedica Omega-3 Supplements for Pet SWOT Analysis
11.5.9 PawMedica Recent Developments
11.6 Vital Pet Life
11.6.1 Vital Pet Life Corporation Information
11.6.2 Vital Pet Life Business Overview
11.6.3 Vital Pet Life Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.6.4 Vital Pet Life Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Vital Pet Life Recent Developments
11.7 StrellaLab LLC
11.7.1 StrellaLab LLC Corporation Information
11.7.2 StrellaLab LLC Business Overview
11.7.3 StrellaLab LLC Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.7.4 StrellaLab LLC Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 StrellaLab LLC Recent Developments
11.8 Waggedy
11.8.1 Waggedy Corporation Information
11.8.2 Waggedy Business Overview
11.8.3 Waggedy Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.8.4 Waggedy Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Waggedy Recent Developments
11.9 Nordic Naturals
11.9.1 Nordic Naturals Corporation Information
11.9.2 Nordic Naturals Business Overview
11.9.3 Nordic Naturals Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.9.4 Nordic Naturals Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Nordic Naturals Recent Developments
11.10 Vetoquinol
11.10.1 Vetoquinol Corporation Information
11.10.2 Vetoquinol Business Overview
11.10.3 Vetoquinol Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.10.4 Vetoquinol Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Vetoquinol Recent Developments
11.11 Nutramax Laboratories, Inc.
11.11.1 Nutramax Laboratories, Inc. Corporation Information
11.11.2 Nutramax Laboratories, Inc. Business Overview
11.11.3 Nutramax Laboratories, Inc. Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.11.4 Nutramax Laboratories, Inc. Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Nutramax Laboratories, Inc. Recent Developments
11.12 Dechra Pharmaceuticals
11.12.1 Dechra Pharmaceuticals Corporation Information
11.12.2 Dechra Pharmaceuticals Business Overview
11.12.3 Dechra Pharmaceuticals Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.12.4 Dechra Pharmaceuticals Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Dechra Pharmaceuticals Recent Developments
11.13 Virbac
11.13.1 Virbac Corporation Information
11.13.2 Virbac Business Overview
11.13.3 Virbac Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.13.4 Virbac Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Virbac Recent Developments
11.14 Grizzly Pet Products
11.14.1 Grizzly Pet Products Corporation Information
11.14.2 Grizzly Pet Products Business Overview
11.14.3 Grizzly Pet Products Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.14.4 Grizzly Pet Products Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Grizzly Pet Products Recent Developments
11.15 Standard Process
11.15.1 Standard Process Corporation Information
11.15.2 Standard Process Business Overview
11.15.3 Standard Process Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.15.4 Standard Process Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Standard Process Recent Developments
11.16 Swedencare
11.16.1 Swedencare Corporation Information
11.16.2 Swedencare Business Overview
11.16.3 Swedencare Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.16.4 Swedencare Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Swedencare Recent Developments
11.17 Veterinarian Recommended Solutions
11.17.1 Veterinarian Recommended Solutions Corporation Information
11.17.2 Veterinarian Recommended Solutions Business Overview
11.17.3 Veterinarian Recommended Solutions Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.17.4 Veterinarian Recommended Solutions Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Veterinarian Recommended Solutions Recent Developments
11.18 Wholistic Pet Organics
11.18.1 Wholistic Pet Organics Corporation Information
11.18.2 Wholistic Pet Organics Business Overview
11.18.3 Wholistic Pet Organics Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.18.4 Wholistic Pet Organics Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Wholistic Pet Organics Recent Developments
11.19 Native Pet
11.19.1 Native Pet Corporation Information
11.19.2 Native Pet Business Overview
11.19.3 Native Pet Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.19.4 Native Pet Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Native Pet Recent Developments
11.20 AdvaCare Pharma
11.20.1 AdvaCare Pharma Corporation Information
11.20.2 AdvaCare Pharma Business Overview
11.20.3 AdvaCare Pharma Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.20.4 AdvaCare Pharma Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 AdvaCare Pharma Recent Developments
11.21 Four Leaf Rover
11.21.1 Four Leaf Rover Corporation Information
11.21.2 Four Leaf Rover Business Overview
11.21.3 Four Leaf Rover Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.21.4 Four Leaf Rover Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Four Leaf Rover Recent Developments
11.22 Shenzhen RedDog Biotechnology Co., Ltd.
11.22.1 Shenzhen RedDog Biotechnology Co., Ltd. Corporation Information
11.22.2 Shenzhen RedDog Biotechnology Co., Ltd. Business Overview
11.22.3 Shenzhen RedDog Biotechnology Co., Ltd. Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.22.4 Shenzhen RedDog Biotechnology Co., Ltd. Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Shenzhen RedDog Biotechnology Co., Ltd. Recent Developments
11.23 Shanghai Chongxing Pet Products Co., Ltd.
11.23.1 Shanghai Chongxing Pet Products Co., Ltd. Corporation Information
11.23.2 Shanghai Chongxing Pet Products Co., Ltd. Business Overview
11.23.3 Shanghai Chongxing Pet Products Co., Ltd. Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.23.4 Shanghai Chongxing Pet Products Co., Ltd. Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.23.5 Shanghai Chongxing Pet Products Co., Ltd. Recent Developments
11.24 Nanjing Xintengrui Biotechnology Co., Ltd.
11.24.1 Nanjing Xintengrui Biotechnology Co., Ltd. Corporation Information
11.24.2 Nanjing Xintengrui Biotechnology Co., Ltd. Business Overview
11.24.3 Nanjing Xintengrui Biotechnology Co., Ltd. Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.24.4 Nanjing Xintengrui Biotechnology Co., Ltd. Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.24.5 Nanjing Xintengrui Biotechnology Co., Ltd. Recent Developments
11.25 Gambol Pet Group Co., Ltd.
11.25.1 Gambol Pet Group Co., Ltd. Corporation Information
11.25.2 Gambol Pet Group Co., Ltd. Business Overview
11.25.3 Gambol Pet Group Co., Ltd. Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.25.4 Gambol Pet Group Co., Ltd. Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.25.5 Gambol Pet Group Co., Ltd. Recent Developments
11.26 Huasheng Weike Bioengineering (Luohe) Co., Ltd.
11.26.1 Huasheng Weike Bioengineering (Luohe) Co., Ltd. Corporation Information
11.26.2 Huasheng Weike Bioengineering (Luohe) Co., Ltd. Business Overview
11.26.3 Huasheng Weike Bioengineering (Luohe) Co., Ltd. Omega-3 Supplements for Pet Product Models, Descriptions and Specifications
11.26.4 Huasheng Weike Bioengineering (Luohe) Co., Ltd. Omega-3 Supplements for Pet Sales, Price, Revenue and Gross Margin (2021-2026)
11.26.5 Huasheng Weike Bioengineering (Luohe) Co., Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Omega-3 Supplements for Pet Industry Chain
12.2 Omega-3 Supplements for Pet Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Omega-3 Supplements for Pet Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Omega-3 Supplements for Pet Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Omega-3 Supplements for Pet Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Omega-3 Supplements for Pet Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Omega-3 Supplements for Pet Market Size Growth Rate by Source, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Omega-3 Supplements for Pet Market Size Growth Rate by Shape, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Omega-3 Supplements for Pet Market Size Growth Rate by Materials, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Omega-3 Supplements for Pet Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Omega-3 Supplements for Pet Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Omega-3 Supplements for Pet Revenue by Region (US$ Million), 2021-2026
Table 7. Global Omega-3 Supplements for Pet Revenue by Region (US$ Million), 2027-2032
Table 8. Global Omega-3 Supplements for Pet Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Omega-3 Supplements for Pet Sales by Region (K Units), 2021-2026
Table 10. Global Omega-3 Supplements for Pet Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Omega-3 Supplements for Pet Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Omega-3 Supplements for Pet Sales Share by Manufacturers (2021-2026)
Table 14. Global Omega-3 Supplements for Pet Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Omega-3 Supplements for Pet Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Omega-3 Supplements for Pet Revenue, 2025
Table 18. Global Omega-3 Supplements for Pet Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Omega-3 Supplements for Pet Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Omega-3 Supplements for Pet Manufacturing Base and Headquarters
Table 21. Global Omega-3 Supplements for Pet Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Omega-3 Supplements for Pet Sales Volume by Source (K Units), 2021-2026
Table 25. Global Omega-3 Supplements for Pet Sales Volume by Source (K Units), 2027-2032
Table 26. Global Omega-3 Supplements for Pet Revenue by Source (US$ Million), 2021-2026
Table 27. Global Omega-3 Supplements for Pet Revenue by Source (US$ Million), 2027-2032
Table 28. Global Omega-3 Supplements for Pet Sales Volume by Shape (K Units), 2021-2026
Table 29. Global Omega-3 Supplements for Pet Sales Volume by Shape (K Units), 2027-2032
Table 30. Global Omega-3 Supplements for Pet Revenue by Shape (US$ Million), 2021-2026
Table 31. Global Omega-3 Supplements for Pet Revenue by Shape (US$ Million), 2027-2032
Table 32. Global Omega-3 Supplements for Pet Sales Volume by Materials (K Units), 2021-2026
Table 33. Global Omega-3 Supplements for Pet Sales Volume by Materials (K Units), 2027-2032
Table 34. Global Omega-3 Supplements for Pet Revenue by Materials (US$ Million), 2021-2026
Table 35. Global Omega-3 Supplements for Pet Revenue by Materials (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Omega-3 Supplements for Pet Sales by Application (K Units), 2021-2026
Table 38. Global Omega-3 Supplements for Pet Sales by Application (K Units), 2027-2032
Table 39. Omega-3 Supplements for Pet High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Omega-3 Supplements for Pet Revenue by Application (US$ Million), 2021-2026
Table 41. Global Omega-3 Supplements for Pet Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Omega-3 Supplements for Pet Growth Accelerators and Market Barriers
Table 45. North America Omega-3 Supplements for Pet Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Omega-3 Supplements for Pet Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Omega-3 Supplements for Pet Growth Accelerators and Market Barriers
Table 48. Europe Omega-3 Supplements for Pet Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Omega-3 Supplements for Pet Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Omega-3 Supplements for Pet Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Omega-3 Supplements for Pet Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Omega-3 Supplements for Pet Growth Accelerators and Market Barriers
Table 53. Southeast Asia Omega-3 Supplements for Pet Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Omega-3 Supplements for Pet Investment Opportunities and Key Challenges
Table 55. Central and South America Omega-3 Supplements for Pet Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Omega-3 Supplements for Pet Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Omega-3 Supplements for Pet Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Barlean’s Corporation Information
Table 59. Barlean’s Description and Major Businesses
Table 60. Barlean’s Product Models, Descriptions and Specifications
Table 61. Barlean’s Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Barlean’s Sales Value Proportion by Product in 2025
Table 63. Barlean’s Sales Value Proportion by Application in 2025
Table 64. Barlean’s Sales Value Proportion by Geographic Area in 2025
Table 65. Barlean’s Omega-3 Supplements for Pet SWOT Analysis
Table 66. Barlean’s Recent Developments
Table 67. Compana Pet Brands Corporation Information
Table 68. Compana Pet Brands Description and Major Businesses
Table 69. Compana Pet Brands Product Models, Descriptions and Specifications
Table 70. Compana Pet Brands Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Compana Pet Brands Sales Value Proportion by Product in 2025
Table 72. Compana Pet Brands Sales Value Proportion by Application in 2025
Table 73. Compana Pet Brands Sales Value Proportion by Geographic Area in 2025
Table 74. Compana Pet Brands Omega-3 Supplements for Pet SWOT Analysis
Table 75. Compana Pet Brands Recent Developments
Table 76. H&H Group Corporation Information
Table 77. H&H Group Description and Major Businesses
Table 78. H&H Group Product Models, Descriptions and Specifications
Table 79. H&H Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. H&H Group Sales Value Proportion by Product in 2025
Table 81. H&H Group Sales Value Proportion by Application in 2025
Table 82. H&H Group Sales Value Proportion by Geographic Area in 2025
Table 83. H&H Group Omega-3 Supplements for Pet SWOT Analysis
Table 84. H&H Group Recent Developments
Table 85. FoodScience Corporation Information
Table 86. FoodScience Description and Major Businesses
Table 87. FoodScience Product Models, Descriptions and Specifications
Table 88. FoodScience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. FoodScience Sales Value Proportion by Product in 2025
Table 90. FoodScience Sales Value Proportion by Application in 2025
Table 91. FoodScience Sales Value Proportion by Geographic Area in 2025
Table 92. FoodScience Omega-3 Supplements for Pet SWOT Analysis
Table 93. FoodScience Recent Developments
Table 94. PawMedica Corporation Information
Table 95. PawMedica Description and Major Businesses
Table 96. PawMedica Product Models, Descriptions and Specifications
Table 97. PawMedica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. PawMedica Sales Value Proportion by Product in 2025
Table 99. PawMedica Sales Value Proportion by Application in 2025
Table 100. PawMedica Sales Value Proportion by Geographic Area in 2025
Table 101. PawMedica Omega-3 Supplements for Pet SWOT Analysis
Table 102. PawMedica Recent Developments
Table 103. Vital Pet Life Corporation Information
Table 104. Vital Pet Life Description and Major Businesses
Table 105. Vital Pet Life Product Models, Descriptions and Specifications
Table 106. Vital Pet Life Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Vital Pet Life Recent Developments
Table 108. StrellaLab LLC Corporation Information
Table 109. StrellaLab LLC Description and Major Businesses
Table 110. StrellaLab LLC Product Models, Descriptions and Specifications
Table 111. StrellaLab LLC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. StrellaLab LLC Recent Developments
Table 113. Waggedy Corporation Information
Table 114. Waggedy Description and Major Businesses
Table 115. Waggedy Product Models, Descriptions and Specifications
Table 116. Waggedy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Waggedy Recent Developments
Table 118. Nordic Naturals Corporation Information
Table 119. Nordic Naturals Description and Major Businesses
Table 120. Nordic Naturals Product Models, Descriptions and Specifications
Table 121. Nordic Naturals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Nordic Naturals Recent Developments
Table 123. Vetoquinol Corporation Information
Table 124. Vetoquinol Description and Major Businesses
Table 125. Vetoquinol Product Models, Descriptions and Specifications
Table 126. Vetoquinol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Vetoquinol Recent Developments
Table 128. Nutramax Laboratories, Inc. Corporation Information
Table 129. Nutramax Laboratories, Inc. Description and Major Businesses
Table 130. Nutramax Laboratories, Inc. Product Models, Descriptions and Specifications
Table 131. Nutramax Laboratories, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Nutramax Laboratories, Inc. Recent Developments
Table 133. Dechra Pharmaceuticals Corporation Information
Table 134. Dechra Pharmaceuticals Description and Major Businesses
Table 135. Dechra Pharmaceuticals Product Models, Descriptions and Specifications
Table 136. Dechra Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Dechra Pharmaceuticals Recent Developments
Table 138. Virbac Corporation Information
Table 139. Virbac Description and Major Businesses
Table 140. Virbac Product Models, Descriptions and Specifications
Table 141. Virbac Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Virbac Recent Developments
Table 143. Grizzly Pet Products Corporation Information
Table 144. Grizzly Pet Products Description and Major Businesses
Table 145. Grizzly Pet Products Product Models, Descriptions and Specifications
Table 146. Grizzly Pet Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Grizzly Pet Products Recent Developments
Table 148. Standard Process Corporation Information
Table 149. Standard Process Description and Major Businesses
Table 150. Standard Process Product Models, Descriptions and Specifications
Table 151. Standard Process Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Standard Process Recent Developments
Table 153. Swedencare Corporation Information
Table 154. Swedencare Description and Major Businesses
Table 155. Swedencare Product Models, Descriptions and Specifications
Table 156. Swedencare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Swedencare Recent Developments
Table 158. Veterinarian Recommended Solutions Corporation Information
Table 159. Veterinarian Recommended Solutions Description and Major Businesses
Table 160. Veterinarian Recommended Solutions Product Models, Descriptions and Specifications
Table 161. Veterinarian Recommended Solutions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Veterinarian Recommended Solutions Recent Developments
Table 163. Wholistic Pet Organics Corporation Information
Table 164. Wholistic Pet Organics Description and Major Businesses
Table 165. Wholistic Pet Organics Product Models, Descriptions and Specifications
Table 166. Wholistic Pet Organics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Wholistic Pet Organics Recent Developments
Table 168. Native Pet Corporation Information
Table 169. Native Pet Description and Major Businesses
Table 170. Native Pet Product Models, Descriptions and Specifications
Table 171. Native Pet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Native Pet Recent Developments
Table 173. AdvaCare Pharma Corporation Information
Table 174. AdvaCare Pharma Description and Major Businesses
Table 175. AdvaCare Pharma Product Models, Descriptions and Specifications
Table 176. AdvaCare Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. AdvaCare Pharma Recent Developments
Table 178. Four Leaf Rover Corporation Information
Table 179. Four Leaf Rover Description and Major Businesses
Table 180. Four Leaf Rover Product Models, Descriptions and Specifications
Table 181. Four Leaf Rover Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Four Leaf Rover Recent Developments
Table 183. Shenzhen RedDog Biotechnology Co., Ltd. Corporation Information
Table 184. Shenzhen RedDog Biotechnology Co., Ltd. Description and Major Businesses
Table 185. Shenzhen RedDog Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 186. Shenzhen RedDog Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Shenzhen RedDog Biotechnology Co., Ltd. Recent Developments
Table 188. Shanghai Chongxing Pet Products Co., Ltd. Corporation Information
Table 189. Shanghai Chongxing Pet Products Co., Ltd. Description and Major Businesses
Table 190. Shanghai Chongxing Pet Products Co., Ltd. Product Models, Descriptions and Specifications
Table 191. Shanghai Chongxing Pet Products Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Shanghai Chongxing Pet Products Co., Ltd. Recent Developments
Table 193. Nanjing Xintengrui Biotechnology Co., Ltd. Corporation Information
Table 194. Nanjing Xintengrui Biotechnology Co., Ltd. Description and Major Businesses
Table 195. Nanjing Xintengrui Biotechnology Co., Ltd. Product Models, Descriptions and Specifications
Table 196. Nanjing Xintengrui Biotechnology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Nanjing Xintengrui Biotechnology Co., Ltd. Recent Developments
Table 198. Gambol Pet Group Co., Ltd. Corporation Information
Table 199. Gambol Pet Group Co., Ltd. Description and Major Businesses
Table 200. Gambol Pet Group Co., Ltd. Product Models, Descriptions and Specifications
Table 201. Gambol Pet Group Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Gambol Pet Group Co., Ltd. Recent Developments
Table 203. Huasheng Weike Bioengineering (Luohe) Co., Ltd. Corporation Information
Table 204. Huasheng Weike Bioengineering (Luohe) Co., Ltd. Description and Major Businesses
Table 205. Huasheng Weike Bioengineering (Luohe) Co., Ltd. Product Models, Descriptions and Specifications
Table 206. Huasheng Weike Bioengineering (Luohe) Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Huasheng Weike Bioengineering (Luohe) Co., Ltd. Recent Developments
Table 208. Key Raw Materials Distribution
Table 209. Raw Materials Key Suppliers
Table 210. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 211. Milestones in Production Technology Evolution
Table 212. Distributors List
Table 213. Market Trends and Market Evolution
Table 214. Market Drivers and Opportunities
Table 215. Market Challenges, Risks, and Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources

List of Figures
Figure 1. Omega-3 Supplements for Pet Product Picture
Figure 2. Global Omega-3 Supplements for Pet Market Size Growth Rate by Source, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Fish Oil-based Omega-3 Supplements Product Picture
Figure 4. Krill Oil-based Omega-3 Supplements Product Picture
Figure 5. Algal Oil-based Omega-3 Supplements Product Picture
Figure 6. Plant-based Omega-3 Supplements Product Picture
Figure 7. Global Omega-3 Supplements for Pet Market Size Growth Rate by Shape, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Liquid Oil Product Picture
Figure 9. Softgel/Capsule Product Picture
Figure 10. Soft Chew Product Picture
Figure 11. Powder Product Picture
Figure 12. Emulsion Product Picture
Figure 13. Global Omega-3 Supplements for Pet Market Size Growth Rate by Materials, 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. EPA and DHA-based Omega-3 Supplements Product Picture
Figure 15. ALA-based Omega-3 Supplements Product Picture
Figure 16. Mixed Omega-3 Supplements Product Picture
Figure 17. Global Omega-3 Supplements for Pet Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 18. Cat
Figure 19. Dog
Figure 20. Others
Figure 21. Omega-3 Supplements for Pet Report Years Considered
Figure 22. Global Omega-3 Supplements for Pet Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 24. Global Omega-3 Supplements for Pet Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 25. Global Omega-3 Supplements for Pet Revenue-Based Market Share by Region (2021-2032)
Figure 26. Global Omega-3 Supplements for Pet Sales (K Units), 2021-2032
Figure 27. Global Omega-3 Supplements for Pet Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 28. Global Omega-3 Supplements for Pet Sales Market Share by Region (2021-2032)
Figure 29. Top 5 and Top 10 Manufacturers Omega-3 Supplements for Pet Sales Volume Market Share in 2025
Figure 30. Global Omega-3 Supplements for Pet Revenue-Based Market Share Ranking (2025)
Figure 31. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 32. Fish Oil-based Omega-3 Supplements Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Krill Oil-based Omega-3 Supplements Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Algal Oil-based Omega-3 Supplements Revenue-Based Market Share by Manufacturer in 2025
Figure 35. Plant-based Omega-3 Supplements Revenue-Based Market Share by Manufacturer in 2025
Figure 36. Global Omega-3 Supplements for Pet Sales Volume-Based Market Share by Source (2021-2032)
Figure 37. Global Omega-3 Supplements for Pet Revenue-Based Market Share by Source (2021-2032)
Figure 38. Global Omega-3 Supplements for Pet ASP by Source (US$/Unit), 2021-2032
Figure 39. Global Omega-3 Supplements for Pet Sales Volume-Based Market Share by Shape (2021-2032)
Figure 40. Global Omega-3 Supplements for Pet Revenue-Based Market Share by Shape (2021-2032)
Figure 41. Global Omega-3 Supplements for Pet ASP by Shape (US$/Unit), 2021-2032
Figure 42. Global Omega-3 Supplements for Pet Sales Volume-Based Market Share by Materials (2021-2032)
Figure 43. Global Omega-3 Supplements for Pet Revenue-Based Market Share by Materials (2021-2032)
Figure 44. Global Omega-3 Supplements for Pet ASP by Materials (US$/Unit), 2021-2032
Figure 45. Global Omega-3 Supplements for Pet Sales Market Share by Application (2021-2032)
Figure 46. Global Omega-3 Supplements for Pet Revenue-Based Market Share by Application (2021-2032)
Figure 47. Global Omega-3 Supplements for Pet ASP by Application (US$/Unit), 2021-2032
Figure 48. North America Omega-3 Supplements for Pet Sales YoY (K Units), 2021-2032
Figure 49. North America Omega-3 Supplements for Pet Revenue YoY (US$ Million), 2021-2032
Figure 50. North America Top 5 Manufacturers Omega-3 Supplements for Pet Sales Revenue (US$ Million) in 2025
Figure 51. North America Omega-3 Supplements for Pet Sales Volume (K Units) by Application (2021-2032)
Figure 52. North America Omega-3 Supplements for Pet Sales Revenue (US$ Million) by Application (2021-2032)
Figure 53. US Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 54. Canada Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 55. Mexico Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 56. Europe Omega-3 Supplements for Pet Sales YoY (K Units), 2021-2032
Figure 57. Europe Omega-3 Supplements for Pet Revenue YoY (US$ Million), 2021-2032
Figure 58. Europe Top 5 Manufacturers Omega-3 Supplements for Pet Sales Revenue (US$ Million) in 2025
Figure 59. Europe Omega-3 Supplements for Pet Sales Volume (K Units) by Application (2021-2032)
Figure 60. Europe Omega-3 Supplements for Pet Sales Revenue (US$ Million) by Application (2021-2032)
Figure 61. Germany Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 62. France Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 63. U.K. Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 64. Italy Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 65. Russia Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 66. Asia-Pacific Omega-3 Supplements for Pet Sales YoY (K Units), 2021-2032
Figure 67. Asia-Pacific Omega-3 Supplements for Pet Revenue YoY (US$ Million), 2021-2032
Figure 68. Asia-Pacific Top 8 Manufacturers Omega-3 Supplements for Pet Sales Revenue (US$ Million) in 2025
Figure 69. Asia-Pacific Omega-3 Supplements for Pet Sales Volume (K Units) by Application (2021-2032)
Figure 70. Asia-Pacific Omega-3 Supplements for Pet Sales Revenue (US$ Million) by Application (2021-2032)
Figure 71. Indonesia Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 72. Japan Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 73. South Korea Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 74. China Taiwan Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 75. India Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 76. Central and South America Omega-3 Supplements for Pet Sales YoY (K Units), 2021-2032
Figure 77. Central and South America Omega-3 Supplements for Pet Revenue YoY (US$ Million), 2021-2032
Figure 78. Central and South America Top 5 Manufacturers Omega-3 Supplements for Pet Sales Revenue (US$ Million) in 2025
Figure 79. Central and South America Omega-3 Supplements for Pet Sales Volume (K Units) by Application (2021-2032)
Figure 80. Central and South America Omega-3 Supplements for Pet Sales Revenue (US$ Million) by Application (2021-2032)
Figure 81. Brazil Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 82. Argentina Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 83. Middle East, and Africa Omega-3 Supplements for Pet Sales YoY (K Units), 2021-2032
Figure 84. Middle East and Africa Omega-3 Supplements for Pet Revenue YoY (US$ Million), 2021-2032
Figure 85. Middle East and Africa Top 5 Manufacturers Omega-3 Supplements for Pet Sales Revenue (US$ Million) in 2025
Figure 86. Middle East and Africa Omega-3 Supplements for Pet Sales Volume (K Units) by Application (2021-2032)
Figure 87. Middle East and Africa Omega-3 Supplements for Pet Sales Revenue (US$ Million) by Application (2021-2032)
Figure 88. GCC Countries Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 89. Turkey Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 90. Egypt Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 91. South Africa Omega-3 Supplements for Pet Revenue (US$ Million), 2021-2032
Figure 92. Omega-3 Supplements for Pet Industry Chain Mapping
Figure 93. Regional Omega-3 Supplements for Pet Manufacturing Base Distribution (%)
Figure 94. Global Omega-3 Supplements for Pet Production Market Share by Region (2021-2032)
Figure 95. Omega-3 Supplements for Pet Production Process
Figure 96. Regional Omega-3 Supplements for Pet Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed